ABBOTT LABORATORIES — Director's Dealing 2016

Feb 24, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2016-02-19

Reporting Person: WHITE MILES D (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-19	Common shares without par value	A	136718	—	Acquired	1530871	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-19	Option (right to buy)	$38.40	A	1198630	Acquired	2026-02-18	Common shares (1198630)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	29402	Indirect
Common shares without par value	8818	Indirect
Common shares without par value	8832	Indirect

Footnotes

F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of February 19, 2016.

F3: The reporting person disclaims beneficial ownership of all securities held by his son.

F4: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 399,544 on 02/19/2017, 399,543 on 02/19/2018, and 399,543 on 02/19/2019.